Related Experiment Video
Updated: Jun 22, 2026
09:34
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
[Levofloxacin (Tavanic) in complex therapy of tuberculosis]
Summary
Levofloxacin effectively treats drug-resistant pulmonary tuberculosis when combined with other antituberculosis drugs. This antibiotic demonstrated safety and efficacy, leading to significant clinical improvement in patients.
Area of Science:
- Pulmonology
- Infectious Diseases
- Pharmacology
Background:
- Drug-resistant tuberculosis poses a significant global health challenge.
- Standard treatment regimens can be lengthy and associated with toxicity.
- Novel therapeutic strategies are needed to improve treatment outcomes.
Purpose of the Study:
- To evaluate the efficacy and safety of levofloxacin in combination with standard antituberculosis drugs.
- To assess levofloxacin's role in treating newly diagnosed drug-resistant pulmonary tuberculosis.
- To determine the clinical utility of levofloxacin in complex and severe tuberculosis cases.
Main Methods:
- A study involving 152 patients with newly diagnosed drug-resistant pulmonary tuberculosis.
- Levofloxacin was administered in combination with first- and second-line antituberculosis drugs.
- Patient outcomes, including clinical improvement and adverse events, were monitored.
Main Results:
- Levofloxacin demonstrated efficacy in treating drug-resistant pulmonary tuberculosis.
- Adverse events related to levofloxacin occurred in 8.6% of cases and were reversible without organ damage.
- Significant clinical improvement was observed, facilitating patient preparation for surgery when necessary.
Conclusions:
- Levofloxacin is a safe and effective option for antituberculosis therapy in patients with drug-resistant pulmonary tuberculosis.
- Its use is particularly beneficial in extended, acute progressing, or polycavernous forms of the disease.
- Levofloxacin can expedite clinical improvement and surgical readiness.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:29Tetanus
Tetanus is a life-threatening neurological disorder characterized by persistent muscle contractions and spastic paralysis. It is caused by Clostridium tetani, a motile, Gram-positive, rod-shaped, obligate anaerobe. These bacteria produce terminal endospores, giving them a distinctive “lollipop” or “tennis-racket” appearance. They thrive in anaerobic environments, such as those found in deep puncture wounds.Once introduced into the body, the spores germinate into vegetative cells. These cells...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...